Daily Trade

This year’s Thanksgiving dinner could stretch your wallet even worse than your waistline.  That’s the dish from the latest American Farm Bureau Federation survey, which has been itemizing the average cost of several dishes traditionally served at Thanksgiving dinner for almost four decades. The Farm Bureau’s shopping list includes enough turkey, stuffing, sweet potatoes, rolls
0 Comments
ContextLogic (NASDAQ:WISH) operates Wish, an e-commerce platform that facilitates transactions between sellers and buyers, focusing on the budget-conscious consumer. Founded by Piotr Szulczewski and Danny Zhang back in 2010, this company has grown rapidly due to its innovative business strategies and easy-to-use platform. However, due to issues surrounding quality on the platform and wider reopenings,
0 Comments
The perfect inflation hedge hasn’t been found. That’s unfortunate, since U.S. inflation has taken a big jump, intensifying the search for an investment that will thrive during times of high inflation. A perfect inflation hedge should satisfy two distinct criteria, and no one yet has figured out how to construct an investment vehicle that does
0 Comments
Shares of online mobile multiplayer video game competition platform Skillz (NYSE:SKLZ) stock are finally recovering, gaining 54% in the last month. After an excellent debut, the stock struggled and lost a lot of steam. But if it pulls back a little more, this looks like an excellent video game stock for your portfolio Source: NYCStock
0 Comments
Progenity (NASDAQ:PROG) is a biotech firm focused on treatments and testing products for a variety of diseases. Historically, PROG stock has been a disappointment. Since its initial public offering (IPO) in 2020, shares dropped from $13 to a low of under $1 per share. Recently, however, Progenity enjoyed a big short squeeze that brought shares
0 Comments
Celltrion Inc.’s shares rallied Monday after the European Commission granted the South Korean biotech firm approval to market its COVID-19 antibody treatment. The European approval of Regdanvimab, marketed by Celltrion as Regkirona in South Korea, drop up the company’s stock price 068270, +9.60% as much as 18% to 251,000 Korean won ($212.72) after the news
0 Comments
Dear MarketWatch, I am 49 years old (turning 50 this year) and my wife is 34. We have two young children under the age of 2, and twin girls, age 11, from my prior marriage. College for the twins is fully funded in a 529 plan and I save monthly in 529 plans for my
0 Comments
With cryptocurrencies posting blistering performances recently, those on the sidelines are increasingly tempted to jump in. At the same time, direct exposure to individual blockchain coins and tokens has its own set of risks outside of market volatility. For an alternative, many have turned to crypto miners like Stronghold Digital Mining (NASDAQ:SDIG) stock. Source: Mark
0 Comments
When Elon Musk polled his Twitter followers over the weekend about whether or not he should sell his Tesla stock, it might have seemed like the typical oddball move for the billionaire entrepreneur. But financial professionals said Musk’s tweet was possibly driven by the desire to employ a smart, end-of-year tax strategy. And they note
0 Comments